New York, July 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Infusion Pumps and Devices: Technologies and Global Markets" - https ...

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing ...

The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of ...

Global, multicenter phase 3 study, co-led by a University of Cincinnati expert, confirms the safety and efficacy of administering Parkinson’s medication via infusion pumps for prolonged symptom relief ...

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing ...

The Infusion Pumps Market has witnessed substantial growth in recent years, fueled by advancements in healthcare technology, a growing prevalence of chronic diseases, and an increasing aging ...

Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, costs, and how each impacts quality of life.

NEWARK, Del, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The infusion pump market is expected to reach US$ 641.7 million by 2023, putting it on the verge of a significant valuation. The expansion is principally ...

The infusion pumps market is expected to grow significantly, with a projected valuation of US$ 641.7 million by 2023. The market exhibits a noteworthy pattern, with a compound annual growth rate (CAGR ...